Background-Type 2 diabetes mellitus (T2DM) is associated with an increased risk of atherosclerotic cardiovascular disease.
A therosclerotic cardiovascular diseases are major causes of morbidity and mortality in the diabetic population. 1 Although the exact mechanisms underlying the association between diabetes and atherosclerotic disease are not known, inflammation has been suggested to play a central role in the development of atherosclerosis. 2 Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) is not only an independent risk factor for atherosclerotic cardiovascular disease but is also associated with increased levels of inflammatory markers. 3 Atherosclerosis is an insidious disorder, and many patients already have atherosclerotic disease before they are diagnosed with diabetes. 4 Impaired glucose tolerance (IGT) is associated with an increased risk of diabetes and has been officially a "prediabetes" state. 5 Many studies have suggested that IGT is associated with an increased risk of atherosclerosis. 6 
Clinical Perspective on p 148
Atherosclerosis is now recognized as an inflammatory disorder. The inflammatory state and composition of atherosclerotic plaques are considered the main contributing factors responsible for acute cardiovascular events, rather than the degree of stenosis. 7 Angiography, the current gold standard imaging modality, is invasive and cannot identify inflamed plaques or nonstenotic plaques, which may be tend to rupture. 8 Therefore, effective techniques for the detection of inflamed vulnerable plaques are critically needed. Recently, positron emission tomography (PET) with fluorodeoxyglucose (FDG) has become one of the best imaging techniques for the detection of vulnerable atherosclerotic plaques. 9 Ogawa et al 10 reported that macrophages are responsible for the accumulation of FDG in atherosclerotic lesions using PET imaging in a rabbit model of atherosclerosis. Moreover, Tawakol et al 11 reported a significant correlation between FDG-PET signal from carotid plaques and macrophage staining from the corresponding histological sections of specimens removed after endarterectomy. Recently, Tahara et al 12, 13 reported that simvastatin treatment for 3 months attenuated plaque inflammation visualized using FDG-PET and FDG uptake in carotid atherosclerosis was higher in proportion to the accumulation to the number of components of the metabolic syndrome (MetS). These studies suggest that FDG-PET imaging may help with measurement of plaque burden, may reflect plaque inflammatory activity, and may be useful in the study of the vascular inflammation response to medical treatment. However, the relationship between the vascular inflammation assessed by FDG-PET and glucose tolerance status has not been studied.
In the present study, we examined the difference in vascular inflammation measured using FDG-PET in patients with normal glucose tolerance (NGT), IGT, and T2DM. We also compared the findings of FDG-PET/CT with the carotid intima-media thickness (IMT), a measure used to quantify atherosclerosis. Furthermore, we evaluated the association between vascular inflammation, predictor of coronary heart disease such as Framingham risk score (FRS), highsensitivity C-reactive protein (hsCRP), and adiponectin, an anti-inflammatory adipokine.
Methods

Study Design and Subjects
We enrolled 30 age-and sex-matched patients with known T2DM (16 men, 14 women; 55.6Ϯ8.6 years of age) and 30 IGT subjects (16 men, 14 women; 54.7Ϯ9.4 years of age) using predefined inclusion and exclusion criteria at the Korea University Diabetes Center. The diagnosis of IGT was based on a 75-g oral glucose tolerance test, according to the criteria of the American Diabetes Association. 14 The mean duration of diabetes in the diabetic subjects was 5.3Ϯ5.9 years, and their mean HbA1c level was 7.1Ϯ1.0%. The types of therapy included diet control only in 2 patients, ␣-glucosidase inhibitor in 3 patients, sulfonylurea in 5 patients, metformin in 10 patients, and both sulfonylurea and metformin in 10 patients. Thirty subjects with NGT (16 men, 14 women; 54.3Ϯ9.1 years of age), matched by age and sex, had no history of T2DM and no clinical evidence of any major disease. They were recruited from subjects presenting for a routine health check-up at the health promotion center of Korea University Guro Hospital. The study exclusion criteria included a history of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization), active inflammatory disease, recent active infection, stage 2 hypertension (resting blood pressure Ն160/100 mm Hg), uncontrolled diabetes mellitus (A 1c Ͼ9%), systemic disorders such as severe hepatic, renal, and hematologic diseases, or taking drugs known to interfere with vascular inflammation measured by FDG-PET. We also excluded subjects taking statin or insulin medication. All participants provided written informed consent and the Korea University Institutional Review Board, in accordance with the Declaration of Helsinki of the World Medical Association, approved this study protocol.
Clinical and Laboratory Assessments
Body mass index (BMI) was calculated as the weight/height 2 (kg/m 2 ), and the waist circumference was measured at the midpoint between the lower border of the rib cage and the iliac crest. All blood samples were obtained in the morning after a 12-hour overnight fast and were immediately stored at Ϫ80°C for subsequent assays. Serum triglycerides and high-density lipoprotein (HDL) cholesterol levels were determined enzymatically using a chemistry analyzer (Hitachi 747, Tokyo, Japan). The low-density lipoprotein (LDL) cholesterol concentration was estimated using the Friedewald formula. 15 A glucose oxidase method was used to measure plasma glucose, and an electrochemiluminescence immunoassay (Roche Diagnostics, Indianapolis, Ind) was used to measure insulin levels. Insulin resistance was calculated by the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). 16 Hemoglobin A1c (HbA1c) was measured using high-performance liquid chromatography (Bio-Rad Variant II, Hercules, Calif). MetS was defined according to the criteria established by the National Cholesterol Education Program Adult Treatment Panel III using the adjusted waist circumference for Asians. 17 An individual 10-year coronary heart disease risk was estimated using the Framingham Heart Study prediction score sheet and used to classify subjects as low, intermediate, or high risk (Ͻ10%, 10% to 20%, and Ͼ20%, respectively). 18, 19 hsCRP levels were measured using a chemiluminescence immunoassay (Beckman, Coulter). Serum adiponectin was measured using an enzyme-linked immunosorbent assay (Mesdia, Seoul, Korea). The intra-assay and interassay variances of adiponectin levels were 4.1% to 5.9% and 3.9% to 6.3%, respectively.
Measurement of the Carotid IMTs
The IMT of the common carotid artery was determined using high-resolution B-mode ultrasonography (EnVisor, Philips Medical Systems, Andover, Mass) with a 5-to 12-MHz transducer. Measurements of the carotid IMT were made using IMT measurement software, Intimascope (Media Cross Co, Tokyo, Japan) at 3 levels of the lateral and medial walls, 1 to 3 cm proximal to the carotid bifurcation. 20 The average IMT was the mean value of 99 computerbased points in the region, and the maximal IMT was the IMT value at the maximal point of the region. All measurements were recorded by a single trained technician who was blinded to the subject's clinical history.
FDG-PET/CT Imaging
PET/CT was performed using the Gemini TF 16 Slice PET/CT scanner (Philips Medical Systems, Cleveland, Ohio), with a 18-cm field of view. TF scanner is a new high-performance, time-of-flight capable, fully 3D PET scanner using lutetium-yttrium oxyorthosilicate crystals. 21 18 F-FDG (370 to 550 MBq) was injected intravenously, and patients rested in a quiet room for 60 minutes. The whole-body PET image (below cerebellum to inguinal) was acquired for 10 minutes (1 minute per bed). PET image analysis was performed on a dedicated workstation (Extended Brilliance Workspace 3.5 with PET/CT viewer for automated image registration, Philips). Right carotid FDG uptake was measured along the length of the right carotid vessel, starting at the bifurcation and extending inferiorly and superiorly every 4 mm. Arterial FDG uptake was quantified by drawing a region of interest around each artery on every slice of the coregistered transaxial PET/CT images. The region of interest was fitted to the artery wall on each axial slice, and coronal and sagittal views were used to ensure that the FDG uptake was from the artery. The standardized uptake value (SUV) is the decay-corrected tissue concentration of FDG (in kBq/mL) divided by the injected dose per body weight (kBq/g). The mean artery SUV value was normalized to the blood pool SUV value measured from the jugular vein (standardized circular regions of interest; right carotid artery, areaϭ77.9Ϯ3.42 mm 2 , 9 pixels; right jugular vein, areaϭ95.0Ϯ12.7 mm 2 , 9 pixels). Afterward, a target-to-background ratio (TBR) was calculated as right carotid vessel plaque SUV divided by venous blood SUV, and a mean and maximum value of TBR was calculated for each patient. 22 To determine the variability of the mean and maximum TBR measurements, images from 20 subjects were twice analyzed, several weeks apart, by 2 readers. The intraobserver and interobserver correlation coefficient values of mean and maximum TBR measurements were Ͼ0.8.
Statistical Analysis
Data are expressed as meanϮSD or median (interquartile range). The normality of distributions of variables was analyzed by KolmogorovSmirnov equality of distribution test. Discrete variables are presented as the total number (percentage). Descriptive data were presented for each category of glucose tolerance and analyzed with ANOVA for normally distributed variables, the Kruskal-Wallis H test for skewed variables, and Fisher exact test, or Pearson 2 test. Subsequent pairwise comparisons were performed by Tukey honestly significant difference post hoc test or Wilcoxon rank-sum test. After adjusting for sex and age, Pearson partial correlation coefficients were calculated to evaluate the relationship between cardiovascular risk factors and the mean and maximum TBR. For nonnormally distributed variables, a natural logarithmic transformation was performed before the partial correlation analysis. Differences in mean and maximum TBR between those with and without MetS were evaluated by the Wilcoxon rank-sum test. The association between maximum TBR and 10-year risk for cardiovascular events was evaluated by testing its relation to the FRS categories. The association between the TBR and each risk factor was assessed by dividing the patients into tertiles on the basis of the maximum TBR, and then ANCOVA with Bonferroni multiple comparison was performed, in which the possible confounding effects of age, sex, and BMI were taken into account by including them in the model as covariates. Data were analyzed using the SPSS for Windows version 12.0 (SPSS, Inc, Chicago, Ill). All statistical results were based on 2-sided tests. A probability value of Ͻ0.05 was considered statistically significant.
Results
The clinical and biochemical characteristics of the study subjects are presented in Table 1 . No significant differences in age, sex distribution, waist circumference, mean and maximum carotid IMT, LDL cholesterol, hsCRP, percentage of smokers, or antihypertensive treatment were found among the groups. BMI, HDL cholesterol, triglyceride, glucose, insulin resistance, HbA1c, and adiponectin levels were significantly different, based on glucose tolerance. Table 2 shows the SUV and TBR measurements by glucose tolerance. Both the SUV and TBR levels were significantly different according to the glucose tolerance status. The mean SUV and TBR levels were significantly higher in patients with T2DM compared with subjects with NGT or IGT. Furthermore, the maximum SUV and TBR levels were increased in patients with IGT and T2DM compared with normal subjects (Figure 1 ). In addition, subjects with MetS showed increased mean TBR (1.5Ϯ0.4 versus 1.2Ϯ0.3, Pϭ0.003) and maximum TBR levels (1.9Ϯ0.6 versus 1.4Ϯ0.4, Pϭ0.001) compared with those without MetS.
The partial correlation analysis, adjusted for age and sex, showed that the mean TBR measurements were significantly positively associated with triglyceride (Pϭ0.013), HOMA-IR (PϽ0.001), and the number of MetS components (Pϭ0.006) and were negatively associated with the HDL cholesterol (Pϭ0.044) and adiponectin levels (Pϭ0.042) ( Table 3) . The results using maximum TBR measurements were similar to those using the mean TBR measurements. Furthermore, mean and maximum TBR levels were significantly correlated with the FRS (PϽ0.001) ( Table 3) . Subjects with intermediate risk (10% to 20%) based on the FRS, as well as those with a high risk (Ͼ20%), showed significantly increased mean and maximum TBR levels compared with those with a low-risk (Ͻ10%) (Pϭ0.001) (Figure 2) . Table 4 shows the clinical and biochemical characteristics stratified by tertiles of maximum TBR levels. According to increments of maximum TBR levels, triglyceride, HOMA-IR, HbA1c, and hsCRP levels were increased. By contrast, HDL cholesterol and adiponectin levels were decreased. Furthermore, the prevalence of the MetS, number of MetS components and the FRS were significantly increased by increments of the maximum TBR levels.
Discussion
The results of the present study showed that patients with T2DM had increased vascular inflammation in areas of carotid atherosclerosis measured using FDG-PET/CT. Moreover, patients with IGT had increased maximum TBR levels compared with NGT subjects even though there was no significant difference in the carotid IMT.
Inflammation is emphasized as a critical factor in the pathogenesis and destabilization of atherosclerotic lesions. 23 Circulating inflammatory markers, such as hsCRP, are known to be associated with cardiovascular disease and are useful for risk stratification of patients with cardiovascular disease. 24 However, circulating inflammatory markers cannot provide information on the vascular inflammation of local individual vascular lesions. Recent animal and clinical studies have shown that FDG-PET might be an accurate and reliable tool for the measurement of vascular inflammation in humans. FDG-PET imaging for vascular inflammation is based on the glycolytic activity of macrophages, which is typically higher than in background tissues. 25 Rudd et al 26 showed that 18 F-FDG-PET detected inflammatory atherosclerotic plaques in 8 patients who first underwent PET imaging and then Correlation coefficients (r) and P values were calculated using the Pearson correlation model. *Logarithmic transformed data were used.
Figure 2.
Maximum TBR levels by Framingham risk score classification in study subjects.
carotid endarterectomy. Towakol et al 11 suggested that there was a significant correlation between the PET signal from the carotid plaques and macrophage staining from corresponding histological sections (rϭ0.70; PϽ0.0001). These studies suggest that FDG-PET imaging can be used for noninvasive identification and quantification of inflammation of atherosclerotic plaques, especially macrophage-related vascular inflammation. 27 Moreover, the reproducibility of FDG uptake measurements is encouraging with correlation coefficients of Ն0.8 on repeat studies, and both mean and maximum TBR measurements were equally reproducible. 22 In the present study using FDG-PET/CT, the maximum TBR levels increased across the category of worsening glucose tolerance. The T2DM subjects exhibited higher maximum TBR levels than the IGT and NGT subjects, and the maximum TBR levels of IGT subjects was significantly higher than the NGT subjects. Rudd et al 22 suggested that the mean TBR might be used for tracking systemic arterial therapies, whereas the maximum TBR might be an optimal measure used for detecting and monitoring local, plaque-based therapy. Carotid artery IMT has been associated with cardiovascular disease and related risk factors in cross-sectional studies 28 and as a predictor of cardiovascular disease in prospective studies. 29 In a recent meta-analysis, the IGT subjects had a significantly greater carotid artery IMT than subjects in the control groups in 3 of 9 studies. 30 Although the carotid IMT determined using high-resolution ultrasonography is one of the best methods for evaluation of atherosclerosis, IMT provides no information on the inflammation associated with atherosclerosis. 31 In the present study, IGT patients did not show a higher carotid IMT, although the maximum TBR values detected by FDG-PET were significantly higher than in the control group. In addition, carotid IMT measurements, in patients with T2DM, also were not different compared with the normal and IGT subjects in the present study. Although the explanation for these findings is not clear, the results might have been affected by the short duration (5.3Ϯ5.9 years) of T2DM among the enrolled patients in this study, with relatively good glucose control (HbA1cϭ7.1Ϯ1.0%). Moreover, we excluded patients with a history of cardiovascular disease in the present study. However, diabetic patients showed an increased in both the mean and maximum TBR levels compared with the normal and IGT subjects. These results suggest that the vascular inflammation detected by FDG-PET might reflect earlier stage dynamic changes of atherosclerosis than the atherosclerotic burden detected by ultrasonography. Tahara et al 12 reported that FDG-PET showed significantly decreased FDG uptake in the atherosclerotic plaques in a simvastatin treatment group after 3 months. These results suggest that FDG-PET can identify a decrease in plaque inflammation much earlier than any structural changes detected by MRI. 32 Dyslipidemia is one of the major risk factors for cardiovascular disease in patients with diabetic mellitus. T2DM patients with higher triglyceride levels might not have substantially higher concentrations of LDL cholesterol than matched individuals without diabetes, but for any LDL cholesterol concentration, those with diabetes generally have an increase in LDL particles because small, dense, lipid-poor LDL particles accumulate in the circulation. 33 It was reported that antioxidant and anti-inflammatory characteristics of HDL cholesterol may be as pivotal as its cholesterol efflux function in terms of protecting against the development of atherosclerosis. 34 Moreover, monocyte-derived macrophages isolated from individuals with low HDL cholesterol concentrations manifest a proinflammatory phenotype. 35 Therefore, mean and maximum TBR may be associated with low HDL cholesterol and increased small, dense LDL particles rather than circulating LDL cholesterol level. The results of this study also showed that hyperglycemia-related variables, such as the fasting plasma glucose and HbA 1c , were significantly associated with the vascular inflammation measured by FDG-PET. Adiponectin is a well-known adipokine that has been associated with protective effects in the vasculature and myocardium. 36 Adiponectin plays a key role as an antidiabetic, insulin-sensitizing factor that has antiatherogenic and anti-inflammatory properties in the vasculature. 36 Epidemiological studies have shown that reduced adiponectin levels are correlated with an increased risk of cardiovascular disease in patients with diabetes and hyperglycemia. 37 In the present study, both the mean and maximum TBR levels were negatively correlated with adiponectin levels and positively correlated with insulin resistance.
Some limitations are observed in our study. First, the principal limitation of this case-control study is the crosssectional design. Therefore, we cannot definitely identify whether increased SUV and TBR measured by FDG-PET were due to worsening glucose tolerance status. However, the present study had several advantages such as the prospective recruitment of subjects with predefined inclusion and exclusion criteria compared with several previous retrospective studies that enrolled patients who had FDG-PET studies for cancer follow-up. Furthermore, we compared the TBR values among groups matched for age and sex because previous studies have reported that the SUV and TBR values differ according to age and sex. 38 Second, circulating insulin levels might alter the expression of glucose transporter (GLUT) isotypes. The most important pathway for FDG to enter the cell body of almost all human cells is mediated by facultative GLUT. 39 Accordingly, the presence of T2DM and IGT might limit the observed difference of SUV between groups. The relationship between the expression of GLUT isotypes and FDG accumulation in atherosclerotic macrophages may be an important area for further investigation.
Conclusion
The results of the present study using FDG-PET/CT showed that patients with IGT, as well as T2DM, had higher maximum TBR levels reflecting vascular inflammation than subjects in the control group. Furthermore, TBR levels were significantly and positively associated with components of the MetS and the FRS and negatively associated with adiponectin levels. These results suggest that FDG-PET/CT might be useful for early diagnosis of vascular inflammation and vulnerable plaques and for estimating the risk stratification of patients with abnormal glucose metabolism. 
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